Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306).
Liu C, You H, Zeng QL, Wong YJ, Wang B, Grgurevic I, Liu C, Yim HJ, Gou W, Dong B, Ju S, Guo Y, Yu Q, Hirooka M, Enomoto H, Hanafy AS, Cao Z, Dong X, Lv J, Kim TH, Koizumi Y, Hiasa Y, Nishimura T, Iijima H, Xu C, Dai E, Lan X, Lai C, Liu S, Wang F, Guo Y, Lv J, Zhang L, Wang Y, Xie Q, Shao C, Liu Z, Ravaioli L, Colecchia A, Li J, Teng GJ, Qi X.
Liu C, et al. Among authors: guo y.
Clin Mol Hepatol. 2024 Jul 11. doi: 10.3350/cmh.2024.0198. Online ahead of print.
Clin Mol Hepatol. 2024.
PMID: 38988296
Free article.